Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Intuitive Surgical Stock Performance
Shares of NASDAQ ISRG opened at $482.21 on Thursday. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $493.97. The stock’s fifty day moving average is $451.45 and its 200 day moving average is $412.69. The stock has a market capitalization of $171.04 billion, a P/E ratio of 87.04, a PEG ratio of 4.97 and a beta of 1.39.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The company had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. During the same quarter last year, the company posted $1.18 EPS. The company’s revenue for the quarter was up 14.5% compared to the same quarter last year. Equities research analysts forecast that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.
Institutional Trading of Intuitive Surgical
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on the stock. JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a research report on Friday, July 19th. Barclays lifted their target price on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a report on Thursday, July 18th. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their target price for the company from $380.00 to $510.00 in a report on Friday, August 2nd. Truist Financial upped their price target on Intuitive Surgical from $450.00 to $515.00 and gave the stock a “buy” rating in a report on Tuesday, July 16th. Finally, Stifel Nicolaus increased their price target on shares of Intuitive Surgical from $430.00 to $475.00 and gave the company a “buy” rating in a report on Friday, July 19th. Six research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $446.45.
Get Our Latest Stock Analysis on ISRG
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- BHP Stock: The Under-the-Radar Growth Story in Commodities
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Analysts Upgrade These 3 Hot Buy-and-Hold Stocks
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Kohl’s Charts a Resilient Path in a Challenging Retail Landscape
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.